The following abstract is drawn from a recently published paper in Journal of Pathology Informatics | ScienceDirect.com by Elsevier. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Falah Jabara, [...]
By Philips, Featuring NYU Langone Health Faced with increasing diagnostic demand, growing complexity in pathology workflows, and a national shortage of pathologists, NYU Langone Health recognized the need for a more scalable and connected diagnostic model. In mid-September 2024, the organization began its transition from traditional microscope-based pathology to a digital workflow. By February 2025, the Manhattan [...]
A new joint white paper from the Royal College of Pathologists and Roche Diagnostics explores how pathology and in-vitro diagnostics can support the NHS’s three planned shifts and contribute to more sustainable healthcare. The Royal College of Pathologists and Roche Diagnostics have published a new joint white paper, Making every test count, exploring the role of diagnostics [...]
The following abstract is drawn from a recently published paper in Journal of Pathology Informatics | ScienceDirect.com by Elsevier. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Joona Pohjonena, [...]
by Rajendra Singh MD Professor of Pathology, University of Pennsylvania Co-Founder, PathPresenter Every few months, someone tells me AI is coming for pathology. More recently, the message has become reassuring: AI isn’t coming for our jobs, it’s just coming for the boring parts. I don’t think either framing gets the real change quite [...]
by Christos Evangelou, MSc, PhD – Medical Writer and Editor A collaborative effort involving universities and research institutes in China and Germany led to the development of a deep learning model trained on standard hematoxylin and eosin (H&E)-stained whole-slide images to predict tumor lactate metabolic status, a feature that is typically assessed using molecular profiling. The researchers validated the [...]
Techcyte, a leader in AI-powered digital pathology, today announced the reorganization of its Board of Directors to support the company’s continued growth and mission to develop the leading digital pathology platform. Ralph Yarro, a Techcyte founder, will continue his service on the board as chairman. Continuing directors also include Karine Sellam, Vice President and Global Head of [...]
Aiforia and Stratipath's collaboration aims to provide pathologists and oncologists with broader access to validated AI-powered diagnostic and prognostic tools and sets the stage for a long-term commercial relationship between the two companies.
Techcyte, a leader in AI-powered digital pathology, and Conflux, a diagnostic intelligence company building AI-native workflows for pathology, today announced a partnership to integrate Conflux directly into the Techcyte Fusion® digital pathology platform. The integration enables pathologists to dictate reports, control report content with natural-language instructions, use existing templates and shortcuts, and complete structured reporting workflows [...]
by Christos Evangelou, MSc, PhD – Medical Writer and Editor Researchers in France conducted a modeling study to estimate the carbon footprint of going fully digital in surgical pathology. The study showed that a hypothetical 100% digital pathology scenario at the national scale could increase a typical lab's greenhouse gas emissions by up to 8%, even without the use of AI to analyze [...]
